ID26945A - PHARMACEUTICAL COMPOSITION THAT CONTAINS MISEL CONSISTS FROM LIPOFILIC GLUCOCORTORTOSTEROID AND ONLY ONE SURFACTANT - Google Patents

PHARMACEUTICAL COMPOSITION THAT CONTAINS MISEL CONSISTS FROM LIPOFILIC GLUCOCORTORTOSTEROID AND ONLY ONE SURFACTANT

Info

Publication number
ID26945A
ID26945A IDW20001131A ID20001131A ID26945A ID 26945 A ID26945 A ID 26945A ID W20001131 A IDW20001131 A ID W20001131A ID 20001131 A ID20001131 A ID 20001131A ID 26945 A ID26945 A ID 26945A
Authority
ID
Indonesia
Prior art keywords
glucocortortosteroid
misel
lipofilic
surfactant
pharmaceutical composition
Prior art date
Application number
IDW20001131A
Other languages
Indonesian (id)
Inventor
Gabrielle Sjoquist
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ID26945A publication Critical patent/ID26945A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDW20001131A 1997-12-22 1998-12-22 PHARMACEUTICAL COMPOSITION THAT CONTAINS MISEL CONSISTS FROM LIPOFILIC GLUCOCORTORTOSTEROID AND ONLY ONE SURFACTANT ID26945A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (en) 1997-12-22 1997-12-22 New formulation

Publications (1)

Publication Number Publication Date
ID26945A true ID26945A (en) 2001-02-22

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001131A ID26945A (en) 1997-12-22 1998-12-22 PHARMACEUTICAL COMPOSITION THAT CONTAINS MISEL CONSISTS FROM LIPOFILIC GLUCOCORTORTOSTEROID AND ONLY ONE SURFACTANT

Country Status (20)

Country Link
EP (1) EP1043973A1 (en)
JP (1) JP2001526210A (en)
KR (1) KR20010024789A (en)
CN (1) CN1283106A (en)
AR (1) AR017220A1 (en)
AU (1) AU1993599A (en)
BR (1) BR9813811A (en)
CA (1) CA2315782A1 (en)
EE (1) EE200000388A (en)
HU (1) HUP0102365A3 (en)
ID (1) ID26945A (en)
IL (1) IL136880A0 (en)
NO (1) NO20003220L (en)
NZ (1) NZ505073A (en)
PL (1) PL341361A1 (en)
SE (1) SE9704833D0 (en)
SK (1) SK9532000A3 (en)
TR (1) TR200001977T2 (en)
WO (1) WO1999032089A1 (en)
ZA (1) ZA9811461B (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (en) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (en) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
CO5310534A1 (en) 2000-08-05 2003-08-29 Glaxo Group Ltd NEW ANDROSTAN ANTI-INFLAMMATORY DERIVATIVES
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
SE0100901D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
ES2314052T3 (en) 2001-04-30 2009-03-16 Glaxo Group Limited ESTER DERIVATIVES OF 17BETA-CARBOTIOATE ANDROSTAN WITH A CYCLIC ESTER GROUP IN THE 17ALFA POSITION.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (en) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 Novel precursor micellar preparation and its production method
EP3354276B1 (en) * 2007-11-13 2020-01-01 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
KR20110056516A (en) * 2008-09-12 2011-05-30 크리티컬 파머수티컬스 리미티드 Improved absorption of therapeutics through mucous membranes or skin
CN101982168B (en) * 2010-11-02 2012-05-23 山东大学 Quercetin nano micelle preparation and preparation method thereof
CN102793678B (en) * 2011-05-26 2017-06-30 邓世明 A kind of preparation method of the Docetaxel injection without tween
DE102011108948A1 (en) * 2011-07-29 2013-01-31 Achim Göpferich Aqueous, colloidal solutions of lipophilic substances, in particular drug solutions
JP5456802B2 (en) * 2012-01-23 2014-04-02 株式会社Ｃａｃ Cell migration promoter and transdermal absorbent for wound treatment
EP3021844B1 (en) * 2013-07-17 2019-11-13 Council of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
KR102086316B1 (en) * 2019-09-09 2020-03-09 한국콜마주식회사 Cosmetic composition having excellent percutaneous absorption property

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
AR002009A1 (en) * 1994-12-22 1998-01-07 Astra Ab PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE MANUFACTURE OF A PROLIPOSOMA POWDER AS USED IN SUCH COMPOSITION, PROCEDURE FOR LAMANUFACTURE OF SUCH COMPOSITION, USE OF SUCH PHARMACEUTICAL COMPOSITION IN THE MANUFACTURE OF A DISPOSAL MEDICINAL PRODUCT.

Also Published As

Publication number Publication date
AU1993599A (en) 1999-07-12
EE200000388A (en) 2002-02-15
HUP0102365A3 (en) 2002-01-28
EP1043973A1 (en) 2000-10-18
WO1999032089A1 (en) 1999-07-01
PL341361A1 (en) 2001-04-09
NZ505073A (en) 2002-09-27
NO20003220L (en) 2000-08-22
CN1283106A (en) 2001-02-07
AR017220A1 (en) 2001-08-22
TR200001977T2 (en) 2000-12-21
SE9704833D0 (en) 1997-12-22
IL136880A0 (en) 2001-06-14
HUP0102365A2 (en) 2001-11-28
SK9532000A3 (en) 2000-11-07
KR20010024789A (en) 2001-03-26
JP2001526210A (en) 2001-12-18
NO20003220D0 (en) 2000-06-21
BR9813811A (en) 2000-10-03
ZA9811461B (en) 1999-06-22
CA2315782A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
ID26945A (en) PHARMACEUTICAL COMPOSITION THAT CONTAINS MISEL CONSISTS FROM LIPOFILIC GLUCOCORTORTOSTEROID AND ONLY ONE SURFACTANT
ID20586A (en) NEW SCELOROGUE AND COSMETIC COMPOSITION THAT CONTAINS NEW COMPOUND
ID23439A (en) 3-PIPERIDYL-4-OXSOKUINAZOLIN DECREASES AND THE SAME PHARMACY COMPOSITIONS
ID25543A (en) ALPHA-ARIL-N-ALKINITRON AND THE PHARMACY COMPOSITION CONTAINING IT
ID25528A (en) SUBSTITUTED CARBOXAMMOTOTIAZOL, THE PRODUCTION AND THE PHARMACY COMPOSITION THAT CONTAINS IT
ID24703A (en) ANTIMICROBIAL QUINOLONS, COMPOSITIONS AND USES
ID22889A (en) ETHYLENA COOPOLYMER COMPOSITION AND ITS USE
PT1041972E (en) COMPRESSED FOR THE INSTANT AND PROLONGED LIBERATION OF ONE OR MORE ACTIVE SUBSTANCES
ID24476A (en) ARILSULFONAMIDA AND ITS ANALOGUE
ID28256A (en) DOUBLE-SUBSTITUTED PROTEASE VARIANTS AND CLEAN COMPOSITION THAT CONTAIN AMILASE VARIES
ID23673A (en) PHARMACEUTICAL FORMULATION CONSIST OF AMOXICILIN AND KLAVULANAT
ID22957A (en) COMPOUND AND ITS USE
ID21683A (en) SOLID PHARMACEUTICAL COMPOSITION CONSIST OF CYCLOSPORINE AND ANIONIC SURFACE MATERIALS
ATE232556T1 (en) EFFORTABLE COMPOSITIONS AND DRY EFFORTABLE GRANULES
ID19824A (en) DITIOLANTS, MANUFACTURING AND ITS EFFECT
ID23807A (en) METHODS AND COMPOSITIONS THAT CONTAIN CEMENTS FOR USE UNDER THE LAND
ID22431A (en) AGROKIMIAN SURFACTANT COMPOSITION
ID24839A (en) TRIAZOL COMPOUNDS AND ITS USE
ID26099A (en) AMIDA DEGREE AND NOSICEPTIN ANTAGONISTS
ID24196A (en) COMPOSITION AND USE
DE69830372D1 (en) GAS-CREATING COMPOSITION AND FORMAS FROM IT
ID24828A (en) PHARMACY COMPOSITIONS OF TIZOKSIANIDA AND NITAZOKSANIDA
ID21764A (en) COMPOSITIONS THAT CONTAIN ANTIJAMUR AND PHOSPHOLIPID
ID23159A (en) WAFER AND ITALY
DE69826138D1 (en) PERFUME COMPOSITION